Dollar General (NYSE: DG) Goes After Family Dollar
Dollar General (NYSE: DG) stock is up today after the company made a bid for Family Dollar.
This comes three weeks after Dollar Tree's first bid for the discount retailer.So who will win this bidding war? Take a look...
Why Family Dollar Stock (NYSE: FDO) Gained 5% From Rival Takeover Bid
Family Dollar stock (NYSE: FDO) finished up 5% on news of a rival takeover bid from Dollar General.So will it be a merger between FDO-DG or FDO-DLTR? Here are the details on which is a better deal for Family Dollar...
Understand and Profit from Surging European Volatility
With the Ukraine conflict advancing to new and dangerous territory, Russia refuses to take Western sanctions lying down.
Led by autocrat Putin, the former Soviet nation is striking back, and as of mid-day Friday the blows remained primarily economic.
And that's where I want to focus today…
Each side continues upping the ante, with ever stronger retaliatory sanctions.
Economic skirmishes like this can quickly escalate into all-out trade wars, where even the victors lose.But you don't have to be another victim. There are steps you can take to mitigate... and profit.
Check Out How Many Overstock Sales Are Done Using Bitcoin
Overstock.com Inc. (Nasdaq: OSTK) said this week that sales on its website paid with Bitcoin are expected to contribute $0.04 per share to the company's full-year fiscal 2014 earnings.But that’s just the start – check out how many sales in Bitcoin it expects going forward…
Alibaba IPO: What an Unorthodox Corporate Structure Means for Shareholders
The Alibaba IPO will be one of the largest U.S. IPOs ever, as most analysts expect the Chinese e-commerce company to raise up to $20 billion through the deal.
The hype surrounding the initial public offering has reached a fever pitch as investors look for any updates about the Alibaba IPO date, IPO price, and the company's financials.And it’s one that will keep power firmly in the hands of the company’s founders. Here's how...
Silver Prices This Week Trade Sideways on Speculator Shorts
Silver prices this week have been slow and steady, continuing an uneventful August during which the white metal has traded in a narrow range.
However, while silver is likely to recoup from its recently slow trading in July, it most likely won't see a prolonged rally anytime soon because the big drivers simply aren't there.Here's why for silver, things are going to get worse before they get better...
JCP Stock in "Recovery Mode" but Still Not a Buy with This Glaring Number
JCP stock was up 1.95% this morning (Friday) following the retailer's release of second-quarter results after market close on Thursday. After hours on Thursday, shares rose more than 10%.
Despite the jump, we're not ready to buy JCP stock.Here's why these earnings numbers don't have us convinced...
The Single Best Investment for the Semiconductor Boom
At first glance two of the major trends reshaping the semiconductor industry seem like polar opposites…
On the one hand, the industry is in the midst of a major boom. On the other, it's also contracting.
For tech investors these conflicting indicators raise two questions:
First, how is this contradiction possible?
Second, and more to the point, how can we make money from it?After looking at the trends, I've come up with a plan for us to outperform the market over the long term with one easy investment...
Pershing Square IPO: Investing in Bill Ackman
Activist investor Bill Ackman announced yesterday that he is planning a Pershing Square IPO, a move that will bring the $15 billion hedge fund public.
As an activist investor, Ackman is known for making big, high-profile bets. Bringing his hedge fund public is just the latest example.For investors will to take a bet on the Pershing Square IPO, here’s what they’d be wagering on…
Cerulean Pharma Inc. (Nasdaq: CERU) Stock Shows the Staggering Gains Biotech Has to Offer
One of yesterday's (Wednesday) biggest stock gainers, Cerulean Pharma Inc. (Nasdaq: CERU), was a biotech company, posting an 30.6% gain by day's end.
This comes at a time when short sellers are adding to their positions, waiting for a downfall of biotech, and even the country's head central banker Janet Yellen has little faith in the sector. Biotech has been on a rally over the last year, a rally that a lot of traders feel has run its course.But biotech is still strong, and here's why...